2.Effect of 2-phenoxyethanol on potency of Sabin inactivated poliomyelitis vaccine and its safety.
Chuan-xiu BIAN ; Shu-de JIANG ; Jian-yong YANG ; Ming-bo SUN ; Ming-xue XIE ; Xin-wen ZHANG ; Guo-yang LIAO ; Wei-dong LI
Chinese Journal of Experimental and Clinical Virology 2007;21(1):44-46
OBJECTIVETo investigate the effect of 2-phenoxyethanol on potency of Sabin inactivated poliomyelitis vaccine (IPV).
METHODSSabin IPV samples containing 5 mg or 7 mg 2-phenoxyethanol each dosage respectively were placed separately at 4 degrees C, 37 degrees C for 2 days and 7 days. D-antigen contents were tested with ELISA method. Then neutralizing antibodies in mice and guinea pigs were detected. The safety experiment was performed according to unusual toxicity test of China requirement for biological product.
RESULTSAfter addition of 2-phenoxyethanol, the I, II, and III D-antigen contents of Sabin IPV did not change. The antibody levels in mice and guinea pigs were not different between experimental group and control group. Animals were safe during observation period.
CONCLUSION2-Phenoxyethanol had no effect on potency and safety of Sabin IPV. It can be used as antiseptic for Sabin IPV.
Animals ; Anti-Infective Agents, Local ; administration & dosage ; pharmacology ; toxicity ; Antigens, Viral ; analysis ; immunology ; Body Weight ; drug effects ; Cercopithecus aethiops ; Drug Stability ; Enzyme-Linked Immunosorbent Assay ; Ethylene Glycols ; administration & dosage ; pharmacology ; toxicity ; Guinea Pigs ; Mice ; Neutralization Tests ; Poliovirus Vaccine, Inactivated ; administration & dosage ; immunology ; toxicity ; Vero Cells
3.Influence of isoniazid on immune function of rat
chuan Bian CAO ; Zhe HUANG ; ju Qiu LI ; fang Xiu HUANG ; hong Yi ZHU ; Ke XIAO ; li Fu HUANG ; Li ZHONG
Drug Evaluation Research 2017;40(8):1094-1097
Objective To study the influence of isoniazid on lymphocyte factor expression and macrophage function of rats.Methods Healthy male SD rats were randomly divided into three groups,which was treated for one month,three months and withdrawal for one month after treated for three months,and each group was randomly divided into isoniazid group and control group.The isoniazid groups were ig with isoniazid at dose of 120 mg/kg every other day and control groups were fed on normal saline.At the corresponding time points,the level of interleukin-12 (IL-12) and interferon-γ (IFN-γ) was detected with ELISA method,detected serum lysozyme content by agar plate method,and Comori method was used for the detection of acid phosphatase levels in peritoneal fluid.Results At all the time points,levels of IL-12,IFN-γ and lysozyme in isoniazid group were not significantly different compared with control group.There were statistically significant differences in acid phosphatase between isoniazid group and control group after treated for one month (P < 0.05),but the significant differences disappeared at the next two time points.Conclusion Isoniazid of 120 mg/kg may have no obvious influence on the immune function of rat.We don't detect the immune injury.
4.Establishment of rhesus model for haploidentical hematopoietic stem cell transplantation with nonmyeloablative conditioning.
Li-Hui LIU ; Qi-Yun SUN ; Kai-Xun HU ; Chuan-Bo FAN ; Ya-Jing HUANG ; Li BIAN ; Xiu-Bin XIAO ; Bo YAO ; Mei GUO ; Chang-Lin YU ; Hui-Sheng AI
Journal of Experimental Hematology 2005;13(4):677-682
To study if rhesus haploidentical hematopoietic stem cell transplantation model can be established by non-myeloablative conditioning, parent monkeys were used as donors, offspring monkeys were used as recipients. The recipient monkeys received a nonmyeloablative conditioning consisting of fludarabine, cyclophosphamide, total body irradiation and rabbit anti-human thymocyte globulin. Cyclosporine, mycophenolate mofetil and anti CD25 antibody were used for GVHD prevention. Donor mobilized peripheral blood stem cells were transplantated on day 0. Hematopoietic recovery, chimerism level, GVHD were assessed regularly. The results indicated that hematopoietic recoveries in all 4 cases were observed within 8 days after transplantation. Donor hematopoietic chimerism could be induced in all cases, chimerism analysis showed full donor chimerism (FDC) in case 3 and 4, and II to III grade GVHD developed on day 12 and 14. In case 1, only low level donor chimerism was detected on day 7, and transplantation rejection happened eventually. Unfortunately, kidney failure happened in case 2 after conditioning and died several days later, chimerism analysis showed 50% donor rate on day 7. It is concluded that the rhesus transplantation model was successfully established by nonmyeloablative conditioning for striding over the MHC barrier. This rhesus monkey model would provide a basis for future research.
Animals
;
Antibodies, Monoclonal
;
administration & dosage
;
Cyclosporine
;
administration & dosage
;
Graft vs Host Disease
;
blood
;
etiology
;
prevention & control
;
Hematopoietic Stem Cell Transplantation
;
adverse effects
;
methods
;
Interleukin-2 Receptor alpha Subunit
;
immunology
;
Karyotyping
;
Macaca mulatta
;
Models, Animal
;
Mycophenolic Acid
;
administration & dosage
;
analogs & derivatives
;
Time Factors
;
Transplantation Chimera
;
blood
;
genetics
;
Transplantation Conditioning
;
methods
;
Transplantation, Homologous